Point-of-care testing of coagulation in patients treated with edoxaban

Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Kuhn, Joachim, Mengel, Annerose, Ziemann, Ulf, Poli, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515947/
https://www.ncbi.nlm.nih.gov/pubmed/32436010
http://dx.doi.org/10.1007/s11239-020-02143-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515947/
https://www.ncbi.nlm.nih.gov/pubmed/32436010
http://dx.doi.org/10.1007/s11239-020-02143-2

Ejemplares similares